title: Hydrodynamic immunization leads to poor CD8 T-cell expansion, low frequency of memory CTLs and ineffective antiviral protection.
abstract: Hepatotropic pathogens, such as hepatitis B (HBV) and hepatitis C (HCV), often escape cellular immune clearance resulting in chronic infection. As HBV and HCV infections are the most common causes of hepatocellular carcinoma (HCC), prevention of these infections is believed to be key to the prevention of HCC. It is believed that an effective immune therapy must induce strong cytotonic T lymphocytes (CTLs) that can migrate into the liver, where they can clear infected hepatocytes. Here, we compared the induction of CD8 T cells by two different DNA immunization methods for T-cell differentiation, function, memory programming and their distribution within relevant tissues in a highly controlled fashion. We used hydrodynamic tail vein injection of plasmid to establish liver-specific LCMV-gp antigen (Ag) transient expression, and studied CD8 T cells induced using the P14 transgenic mouse model. CD8 T cells from this group exhibited unique and limited expansion, memory differentiation, polyfunctionality and cytotoxicity compared with T cells generated in intramuscularly immunized mice. This difference in liver-generated expansion resulted in lower memory CD8 T-cell frequency, leading to reduced protection against lethal viral challenge. These data show an unusual induction of naive CD8 T cells contributed to the lower frequency of Ag-specific CTLs observed after immunization in the liver, suggesting that limited priming in liver compared with peripheral tissues is responsible for this outcome.
authors: Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
authors: N
authors: N
authors: Obeng-Adjei
authors: D K
authors: DK
authors: Choo
authors: D B
authors: DB
authors: Weiner
mesh_terms: D056704:Adaptive Immunity / Q000276:immunology; D000595:Amino Acid Sequence; D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D006023:Glycoproteins / Q000276:immunology; D022781:Hepatocytes / Q000276:immunology* / Q000473:pathology; D057446:Hydrodynamics; D007114:Immunization / Q000379:methods; D007156:Immunologic Memory; D008114:Liver Neoplasms, Experimental / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control; D008213:Lymphocyte Activation; D008217:Lymphocytic choriomeningitis virus / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000473:pathology; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000276:immunology
chemical_list: D000956:Antigens, Viral; D006023:Glycoproteins; D019444:Vaccines, DNA
references: Science. 1996 Apr 5;272(5258):54-60
references: 8600537
references: Eur J Immunol. 1998 Jan;28(1):221-36
references: 9485202
references: J Immunol. 2006 Jul 15;177(2):831-9
references: 16818737
references: Infect Immun. 2010 Jan;78(1):168-76
references: 19884330
references: Hepatology. 2001 Jan;33(1):287-94
references: 11124847
references: Int Immunol. 1999 Aug;11(8):1225-38
references: 10421780
references: J Hepatol. 2002 Jan;36(1):105-15
references: 11804672
references: Nature. 2003 Jul 3;424(6944):88-93
references: 12840763
references: PLoS One. 2009 Oct 30;4(10):e7619
references: 19876399
references: Gastroenterology. 2008 Sep;135(3):989-97
references: 18619445
references: J Exp Med. 2007 Apr 16;204(4):771-80
references: 17389236
references: J Gene Med. 2004 Aug;6(8):877-83
references: 15293346
references: J Immunol. 2010 Mar 15;184(6):2873-85
references: 20154206
references: J Clin Invest. 2008 May;118(5):1835-45
references: 18398508
references: Science. 2001 Mar 23;291(5512):2413-7
references: 11264538
references: J Hepatol. 2011 Feb;54(2):357-65
references: 21084131
references: Mol Ther. 2011 Mar;19(3):450-60
references: 21081900
references: Vaccine. 2008 Sep 19;26(40):5210-5
references: 18455277
references: Hum Gene Ther. 1999 Jul 1;10(10):1735-7
references: 10428218
references: J Immunol. 2003 Jul 1;171(1):27-31
references: 12816979
references: J Immunol. 2006 Aug 1;177(3):1689-97
references: 16849478
references: J Cell Sci. 1992 Dec;103 ( Pt 4):1249-59
references: 1487500
references: J Exp Med. 2010 Mar 15;207(3):553-64
references: 20156972
references: J Immunol. 2001 May 1;166(9):5430-8
references: 11313380
references: Adv Immunol. 1999;72:209-53
references: 10361577
references: Eur J Immunol. 1994 Dec;24(12):3106-12
references: 7528669
references: Eur J Cardiothorac Surg. 2006 Aug;30(2):362-9
references: 16828564
references: J Immunol. 2010 Nov 15;185(10):5751-61
references: 20937846
references: Vaccine. 2011 Sep 9;29(39):6755-62
references: 21238574
references: Immunity. 1998 Feb;8(2):177-87
references: 9491999
references: Science. 2012 Jun 29;336(6089):1676-81
references: 22745423
references: J Exp Med. 2008 Dec 22;205(13):3019-29
references: 19047437
references: Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13825-30
references: 12374864
references: J Hepatol. 2012 Oct;57(4):830-6
references: 22659099
references: J Immunol. 2012 Jul 15;189(2):638-45
references: 22706075
references: Hepatology. 2010 Sep;52(3):1068-77
references: 20607836
references: Blood. 2006 Jun 15;107(12):4781-9
references: 16467198
references: Curr Opin Immunol. 2006 Jun;18(3):255-64
references: 16632337
references: Immunol Rev. 2002 Aug;186:221-33
references: 12234374
references: J Immunol. 1999 May 1;162(9):5173-7
references: 10227989